The Oral Contraceptive PPI: Its Effect on Patient Knowledge,Feelings,and Behavior

Abstract

The distribution of the PPI by pharmacists is at best controversial. Although most health professionals agree that the patient has a right to receive information about drugs, they disagree on the best way to provide that information. Since the oral contraceptive PPI has been in routine use for approximately 10 years, a large data base exists that can be used to determine not only patient acceptance of the PPI, but also knowledge, feelings, and behavior secondary to the PPI. In this study, 50 women of childbearing age completed a questionnaire, and it was learned that 84 percent had taken or were currently taking oral contraceptives, and 90 percent of those received a PPI; however, only 61 percent of these women read all of it. The women performed poorly on the knowledge exam (mean ± SD, 44.5 ± 21.2, range, 0–83 percent); those who read all of the PPI or who were white had higher scores (p < 0.02 and p < 0.001, respectively). Thirty-eight percent of the women thought that the PPI information was inadequate, suggesting that it needs to be rewritten and/or supplemented with information from pharmacists. After reading the PPI, 12 percent contacted their pharmacist for additional information. Pharmacists are in a unique position to provide oral contraceptive information that enables women to make informed judgments regarding benefit: Risk ratios on a personal basis.

Keywords

patient package insert (PPI)oral contraceptives

Get full access to this article

View all access options for this article.

References

Small

. On PPIs, Am Pharm 1981;NS 21: 9.

Liquori

. Assessment of the readability of PPIs. Drug Intell Clin Pharm 1978; 12: 712–6.

Morris

. Rationale for patient package inserts. Am J Hosp Pharm 1978; 35: 179–84.

Morris

. Patient package inserts. Pub Health Rep 1977; 92: 421–7.

Joubert

Lasagna

. Patient package inserts IV. Clin Pharmacol Ther 1975; 18: 663–9.

Dorsey

. The patient package insert. JAMA 1977; 238: 1936–9.

Fleckenstein

Joubert

Lawrence

Patsner

Mazzullo

Lasagna

. Oral contraceptive patient information. JAMA 1976; 235: 1331–6.

Joubert

Lasagna

. Patient package inserts I. Clin Pharmacol Ther 1975; 18: 507–13.

Food and Drug Administration. Survey of consumer's perceptions of patient package inserts for oral contraceptives. PB 248–739/AS. Springfield, Va: National Technical Information Service, (Sept) 1975.

10.

FDC Reports. The Pink Sheet. 1981; 43: 13.

11.

FDC Reports. The Pink Sheet. 1981; 43: 17–8.

12.

FDC Reports. The Pink Sheet. 1982; 43: 11–3.

13.

Kay

. Breast cancer and oral contraceptives. Br Med J 1981; 282: 2089–93.

14.

Morris

. A sampler of printed patient oriented prescription drug materials. Drug Intell Clin Pharm 1978; 12: 161–8.

15.

Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press, 1979.